SuperworthProtara Therapeutics shares outstanding TARA
Diluted shares outstanding, averaged over each quarter, from 2013.
- Latest quarter, to Jun 30, 2026
- 61M
- On a year earlier
- +44.3%
- more shares
Protara Therapeutics had 61M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 44.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 46M | +69% |
| FY2024 | 27.3M | +140% |
| FY2023 | 11.4M | +1% |
| FY2022 | 11.3M | +0% |
| FY2021 | 11.2M | +1% |
| FY2020 | 11.2M | +2016% |
| FY2019 | 528K | +10% |
| FY2018 | 480.5K | +9% |
| FY2017 | 440.5K | +6% |
| FY2016 | 414.9K | +1% |
| FY2015 | 412.3K | +6773% |
| FY2013 | 6K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 61M | +44% | |
| Q1 FY26 | 57.5M | +41% | |
| Q4 FY25 | 46M | +69% | |
| Q3 FY25 | 42.3M | +89% | |
| Q2 FY25 | 42.3M | +99% | |
| Q1 FY25 | 40.7M | +256% | |
| Q4 FY24 | 27.3M | +140% | |
| Q3 FY24 | 22.3M | +97% | |
| Q2 FY24 | 21.2M | +88% | |
| Q1 FY24 | 11.4M | +1% | |
| Q4 FY23 | 11.4M | +1% | |
| Q3 FY23 | 11.3M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Protara Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.